Clinical trial data in particular is instrumental; it aids researchers with insights that can help develop new therapies, drugs and other treatments. But historically, clinical trial data hasn’t been easy for researchers to access. Hunting down disparate datasets for comparison and further analysis is a lengthy, multitouch process. And requesting access to this sensitive data is notoriously cumbersome.

Vivli’s mission was to change that for good. In 2018, Vivli had been in talks with one of our top strategic partners, Microsoft, to discuss what it would take to build an intuitive data-sharing platform. The platform would provide researchers access to completed clinical trial data submitted by industry and academic researchers across important therapeutic areas including oncology, cardiology, rheumatology and much

Scroll al inicio